Hepatocellular carcinoma
PIVKA-II been identified as a promising biomarker with utility in the surveillance, diagnosis, and management of HCC.
Hepatocellular carcinoma
PIVKA-II been identified as a promising biomarker with utility in the surveillance, diagnosis, and management of HCC.
Heart Failure
NT-proBNP as the gold standard biomarker in heart failure to support clinical decision at every stage of heart failure
Heart Failure risk in patients with Type 2 Diabetes
NT-proBNP can be used to assess the risk of heart failure in patients with Type 2 Diabetes.